Study on the Effectiveness of the MTT24.5 Cognitive Training Program on Cognitive Skills, Brain Volume, and Activation
NCT ID: NCT06549517
Last Updated: 2024-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
75 participants
INTERVENTIONAL
2023-03-02
2023-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The Main Questions it aims to answer are:
Does MTT24.5 improve overall cognitive performance and specific areas like memory, attention, and language skills? What effects does MTT24.5 have on brain volume and activation? How well do participants follow the program, and what are their response patterns?
Study Design
* Researchers will compare the results of participation in the MTT24.5 training versus a control group with no intervention. Participants will be randomly assigned to either the MTT24.5 program or the control group.
* The study involves adults aged 30 and older from the general population who do not have clinical cognitive impairment.
* The intervention includes attending 12 weekly in-person sessions, each lasting about 2 hours, for a total of 24.5 hours.
* The study will assess cognitive performance, brain volume, and activation, as well as monitor adherence to the program and response patterns.
Participants will:
* Engage in the MTT24.5 program or the control condition as assigned.
* Complete cognitive assessments to measure performance in various domains.
* Undergo brain imaging to evaluate changes in brain volume and activation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility Testing of Cognitive Strategy Training in Post-Concussive Syndrome
NCT04681742
Feasibility of a Motor-cognitive Training Program in Patients With Traumatic Brain Injury
NCT06149975
Rehabilitation of Working Memory and Brain Plasticity After Traumatic Brain Injury: Plastim-MDTC
NCT03513133
Enhancing Motor Task Training by Action Observation Watching Others Perform the Task
NCT00393432
Walking and Balance Post-TBI
NCT01418976
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
II) AIMS:
Primary Objectives:
Evaluate the effects of MTT24.5 on cognitive abilities such as memory, attention, orientation, verbal fluency, language, and visuospatial skills.
Assess the effects of MTT24.5 on brain structure and activation, including brain volumes in globally standardized areas and those associated with cognitive abilities, according to cognitive brain areas with taxonomic mapping.
Determine if there are response phenotypes based on individual baseline characteristics, such as age, gender, lifestyle factors, medical history, medications, family history of dementia, diet, and baseline cognitive reserve score.
Secondary Objective:
Analyze the tolerance and adherence to MTT24.5 and its association with outcomes related to cognitive variables, as well as structural and/or functional brain changes.
III) METHODS
Design:
This is a multisite, prospective, randomized open clinical study conducted between March and October 2023.
Regulatory Approvals:
The trial was approved by the review board and the local ethics committee. All participants provided written consent. This study followed the Consolidated Standards of Reporting Trials (CONSORT) reporting guideline.
Evaluations:
* Cognitive Reserve Score (CRS): A validated cognitive reserve scale authorized from Roldan L. et al. The CRS records the frequency of cognitively stimulating activities carried out throughout life. It includes 24 items distributed across four aspects: activities of daily living, education/information, hobbies, and social life. The CRS will be obtained for each subject at baseline (pre-intervention) and after 12 weeks of participation.
* Medical and Lifestyle History Form: A self-administered medical and lifestyle history form called STEPS 5, adapted from www.who.int/chp/steps, and previously used in the Latin American OPTIMO study. This form will be administered to each subject at baseline (pre-intervention).
* The Addenbrooke's Cognitive Examination-III (ACE-III): A brief cognitive test that evaluates five cognitive abilities: attention, memory, verbal fluency, language, and visuospatial skills. The ACE-III score will be obtained for each subject at baseline (pre-intervention) and post-intervention.
* Brain Magnetic Resonance Imaging (BMRI): Brain volume and activation information will be obtained from this study, conducted on a subset of subjects at baseline (pre-intervention) and post-intervention.
Description of the Intervention:
MTT24.5 is a structured program consisting of 40 new pieces of knowledge and 100 learning techniques.developed as a binomial DATA/TECH program, provides the brain with new knowledge (DATA) classified into formal, natural, social, and cultural areas. The TECH consists of 100 high-impact cognitive stimulation modalities designed to enhance memory, attention, verbal fluency, and visuospatial skills. Techniques include methods such as learning to read the information in Braille, writing it with the non-dominant hand, or reinforcing the concept across various domains simultaneously. Each piece of new information and technique is codified and identified with a number throughout the protocol. This integration is intended to promotes changes in brain functionality, improves synaptic efficiency, and achieves permanent plastic changes. The program spans approximately 24.5 hours over 12 weeks, comprising weekly in-person training sessions of 1.5 hours each, supplemented by an additional average of 4 hours of weekly online activities.
The data or new knowledges were selected through an extensive search of relevant knowledge from the basic sciences (natural, cultural, formal, and social sciences). To be included, the data should be expressible in a concise concept stated in a maximum of 15 words, around which an explanation is built using visual animation and emotional aspects or experiential learning during a 10-minute session. The second part of the session aims to promote the integration of the new knowledge into an individual's cognitive reserve, employing cognitive TECHS, which consist of exercises designed for this purpose. TECHS selection was based on a review of peer-reviewed articles demonstrating the effectiveness of cognitive training in improving specific cognitive abilities investigated in the study. We identified 25 cognitive training studies with appropriate tools published between 2000 and 2022. The possible combinations of these tools yielded 75 possibilities regarding the association between 2 to 5 techniques for learning the same data, indicating either consecutive or simultaneous actions.
24.5 represents the total hours assigned to the program duration, based on similar training distributions reported in the ACTIVE TRIAL (The Advanced Cognitive Training for Independent and Vital Elderly).
Detailed descriptions of the statistical analysis plan can be found in the attached document, SA
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group-MTT24.5
Subjects are assigned to 12 cognitive training in-person sessions of the MTT245 program by a validated trainer. Cognitive evaluations are made initially week 1 and at the end of the intervention at week 12.
Cognitive training
MTT24.5 consists in the learning of 40 new datas or knowledges, along 24.5 hours distributted on classes or sessions, during which an average of 3.5 new pieces of knowledge are taught and reinforced through training. Participants are trained using 4 techniques assigned to each new piece of information from a total of 100 available techniques. These techniques include the use of non-dominant skills, literacy in Braille for sighted individuals, and performing 5 actions simultaneously. Each technique is designed to aid in the memorization and learning of new knowledge
Control group
Subjects are assigned to a controlled arm whereas no intervention were done. They should underwent the same cognitive evaluations than active comparator at week 1 and 12.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cognitive training
MTT24.5 consists in the learning of 40 new datas or knowledges, along 24.5 hours distributted on classes or sessions, during which an average of 3.5 new pieces of knowledge are taught and reinforced through training. Participants are trained using 4 techniques assigned to each new piece of information from a total of 100 available techniques. These techniques include the use of non-dominant skills, literacy in Braille for sighted individuals, and performing 5 actions simultaneously. Each technique is designed to aid in the memorization and learning of new knowledge
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to understand instructions for the training tasks.
* Addenbrooke Cognitive Examination score \>70.
Exclusion Criteria
* Hearing, visual, or motor deficits that would impede participation in the program.
* History of severe degenerative neurological diseases, as these conditions may significantly impact brain plasticity and cognitive abilities.
* History of severe psychiatric disorders, as they may influence brain reorganization and complicate the interpretation of results.
* Unstable treatment or planned changes in medication that may affect brain function and alter results.
* History of current or recent excessive substance use (within the past 6 months), including alcohol or drugs, as these substances may influence brain function and neuroplasticity.
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institute for Biomedical Research, CONICET
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carol Kotliar
Chief Clinical Research Laboratory
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carol V Kotliar, PhD
Role: PRINCIPAL_INVESTIGATOR
BIO
Carol V Kotliar, PhD
Role: PRINCIPAL_INVESTIGATOR
Institute for Biomedical Research, CONICET
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Espacio Santa Maria
San Isidro, Buenos Aires, Argentina
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, Costafreda SG, Dias A, Fox N, Gitlin LN, Howard R, Kales HC, Kivimaki M, Larson EB, Ogunniyi A, Orgeta V, Ritchie K, Rockwood K, Sampson EL, Samus Q, Schneider LS, Selbaek G, Teri L, Mukadam N. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020 Aug 8;396(10248):413-446. doi: 10.1016/S0140-6736(20)30367-6. Epub 2020 Jul 30. No abstract available.
Lindenberger U. Human cognitive aging: corriger la fortune? Science. 2014 Oct 31;346(6209):572-8. doi: 10.1126/science.1254403.
Ball K, Berch DB, Helmers KF, Jobe JB, Leveck MD, Marsiske M, Morris JN, Rebok GW, Smith DM, Tennstedt SL, Unverzagt FW, Willis SL; Advanced Cognitive Training for Independent and Vital Elderly Study Group. Effects of cognitive training interventions with older adults: a randomized controlled trial. JAMA. 2002 Nov 13;288(18):2271-81. doi: 10.1001/jama.288.18.2271.
Snowdon DA; Nun Study. Healthy aging and dementia: findings from the Nun Study. Ann Intern Med. 2003 Sep 2;139(5 Pt 2):450-4. doi: 10.7326/0003-4819-139-5_part_2-200309021-00014.
Rebok GW, Ball K, Guey LT, Jones RN, Kim HY, King JW, Marsiske M, Morris JN, Tennstedt SL, Unverzagt FW, Willis SL; ACTIVE Study Group. Ten-year effects of the advanced cognitive training for independent and vital elderly cognitive training trial on cognition and everyday functioning in older adults. J Am Geriatr Soc. 2014 Jan;62(1):16-24. doi: 10.1111/jgs.12607. Epub 2014 Jan 13.
Feingold A. New Approaches for Estimation of Effect Sizes and their Confidence Intervals for Treatment Effects from Randomized Controlled Trials. Quant Method Psychol. 2019;15(2):96-111. doi: 10.20982/tqmp.15.2.p096.
Masic V, Secic A, Trost Bobic T, Femec L. Neuroplasticity and Braille reading. Acta Clin Croat. 2020 Mar;59(1):147-153. doi: 10.20471/acc.2020.59.01.18.
Kotliar C, Olmos L, Koretzky M, Jauregui R, Delia T, Cingolani O. A new program for systematically enhancing cognitive reserve in healthy adults: A pilot randomized active-controlled clinical trial. PLoS One. 2025 Oct 1;20(10):e0331193. doi: 10.1371/journal.pone.0331193. eCollection 2025.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MTT245Cog
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.